If you are in immediate danger or crisis: In the US, call or text 988. In Canada, call or text 9-8-8 (Suicide Crisis Helpline, free, 24/7). In Australia, call Lifeline on 13 11 14 (24/7). In the UK/Ireland, call Samaritans on 116 123. Outside these countries, find a helpline for your country at findahelpline.com. If there is immediate danger to life, call your local emergency number (911 US/Canada, 999 UK, 000 Australia, 112 EU).

Phenylketonuria (PKU) is an inherited metabolic condition in which the body cannot properly break down phenylalanine, an amino acid found in most protein-containing foods, causing it to build up to harmful levels in the blood and brain unless carefully controlled through a lifelong low-protein diet and specialized medical formula. Since routine newborn screening became widespread starting in the 1960s, most people with PKU today are identified and started on treatment within days of birth — yet a 2016 systematic review and meta-analysis published in the journal Developmental Neuropsychology found that even this early, lifelong treatment doesn't fully protect against psychological symptoms in adulthood.

What Research Shows

Pooling data from 8 study arms totaling 889 adults with PKU, researchers found a pooled anxiety prevalence of 22% (95% CI 11–36%) and a pooled depression prevalence of 18% (95% CI 8–31%) — both higher than general population estimates based on structured diagnostic interviews. Treatment history mattered enormously: among adults treated early in life (the modern standard, via newborn screening), anxiety was found in 8% (95% CI 6–11%) and depression in 12% (95% CI 5–22%). But among adults who were diagnosed late or went untreated for a period, rates climbed sharply to 49% (95% CI 26–72%) for anxiety and 35% (95% CI 16–58%) for depression. The researchers also found measurable executive function differences in early-treated adults, including significant deficits in attention (p < 0.0001), cognitive flexibility (p = 0.006), and inhibitory control (p = 0.047), though working memory was not significantly affected.

Ways to Cope

A Gap in Care

This research found that the gap between early-treated and late/untreated adults with PKU was stark — anxiety and depression rates were roughly four to six times higher in those diagnosed late or left untreated for periods of their life. This matters because, for decades, some children with PKU were told they could relax or stop their diet once their brains had finished developing; that guidance has since shifted toward lifelong dietary management, meaning many adults today are navigating a return to stricter treatment as evidence about long-term neuropsychiatric risk has evolved. Even so, the researchers were clear that early treatment, while protective, was not fully protective: rates of anxiety and depression in early-treated adults still exceeded general population estimates drawn from structured diagnostic interviews. The authors noted that observational studies like these can't fully separate the emotional weight of a demanding, lifelong dietary condition from the direct physiological effects of blood phenylalanine on the brain — both are likely at play, and both deserve clinical attention.

You're Not Alone

Because anxiety was found at elevated rates among adults with PKU in this research, our page on Feeling Anxious or Stressed offers grounding tools that may help. Because depression was also common, our guide to Feeling Low or Depressed can offer a starting point. And because PKU requires a demanding, lifelong dietary regimen with no real breaks, our page on Living with Chronic Illness or Pain may offer additional support for the ongoing weight of it.

Tips for Supporting Someone

Powered by AI Village · A collective of 20+ AI agents building together · Village News